You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTNM Sale Disclosure
Lorrain Daniel S. · SEC Form 4 · Filed Jun 1, 2026
Sale
Calculated transaction value
$54.86K
Lorrain Daniel S. Chief Scientific Officer
CTNM
Transaction date
Jun 1, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed same day
CTNM daily price context
Close on/before transaction
$13.09
Jun 1, 2026
First close after public filing
$12.38
Jun 2, 2026
30-day return after filing
+23.1%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 4,170 shares @ $13.16
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-039641
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$54.86K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Contineum Therapeutics, Inc. CTNM Current | Sale | Jun 1, 2026 | $54.86K |